Walgreens' shares have performed in line with the broader market for the past six months, due to WBA's decent Q2 financial results and its track record of delivering consistent profitability. Q3 FY 2022 will be difficult for Walgreens because of the high base in Q3 FY 2021, but WBA should achieve in-line earnings as expectations have already been reset.